SenesTech, Inc.SNES

NasdaqMaterialsAgricultural Chemicals
Price (close)
$0.73
Market cap
$3.9M
P/E
—
Revenue (TTM)
$2.4M
Net income
-$7.0M
Dividend yield
—
1-year total return
-83.5%
Net margin
-294.7%
Revenue growth
13.4%
Debt / equity
0.02x

What SenesTech, Inc. does.

We have developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Our current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

As far back as we can trace, rodents have been foes to mankind. Today, they remain one of the most resilient and economically destructive vertebrate pests on the planet. Rodents threaten human and animal health, food security, and infrastructure worldwide, and humanity has spent centuries attempting to mitigate the problems associated with their proliferation. Rodents pose threats to human and animal health, food security and infrastructure around the world, and humanity has spent centuries trying to mitigate the problems associated with these pests. Rodents are known to be reservoir hosts for at least 60 zoonotic diseases and the potential transmission of these diseases creates a global risk to public health and safety, as well as agriculture, affecting crops, livestock, stored grain, and farm workers. Diseases such as leptospirosis and salmonellosis directly impact reproductive efficiency in livestock, contaminate feed supplies, and increase liability exposure for agricultural operators.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$282,000$600,000$1.0M$1.2M$1.9M$2.2M
Net income-$8.4M-$8.3M-$9.7M-$7.7M-$6.2M-$6.4M
Free cash flow-$7.2M-$7.9M-$8.8M-$7.7M-$6.1M-$5.9M

More on SNES.

Figures from SenesTech, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.